
Varex Imaging Corporation VREX
$ 12.07
0.0%
Quarterly report 2025-Q4
added 02-10-2026
Varex Imaging Corporation Total Liabilities 2011-2026 | VREX
Annual Total Liabilities Varex Imaging Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 621 M | 670 M | 669 M | 638 M | 651 M | 674 M | 594 M | 562 M | 661 M | 96.4 M | 88 M | 73.8 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 674 M | 73.8 M | 500 M |
Quarterly Total Liabilities Varex Imaging Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 607 M | 621 M | 604 M | 794 M | 778 M | 670 M | 657 M | 662 M | 659 M | 669 M | 667 M | 658 M | 656 M | 638 M | - | 628 M | 633 M | 651 M | 676 M | 651 M | 606 M | 674 M | 674 M | 674 M | - | 580 M | 580 M | 580 M | 561 M | 548 M | 548 M | 548 M | 611 M | 650 M | 650 M | 650 M | 81.1 M | 86.1 M | 86.1 M | 86.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 794 M | 81.1 M | 580 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
27.2 M | $ 3.28 | - | $ 123 M | ||
|
Electromed
ELMD
|
10.6 M | $ 25.74 | - | $ 218 M | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Globus Medical
GMED
|
730 M | $ 90.74 | - | $ 12.3 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.08 | - | $ 1.26 M | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 13.38 | - | $ 1.81 B | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.23 | - | $ 50 M | ||
|
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Orthofix Medical
OFIX
|
401 M | $ 11.91 | - | $ 472 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Insulet Corporation
PODD
|
1.68 B | $ 182.87 | - | $ 12.9 B | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.6 | -1.96 % | $ 37.3 M | ||
|
Sintx Technologies
SINT
|
6.58 M | $ 2.15 | - | $ 5.96 M | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 11.08 | - | $ 314 M | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
Stryker Corporation
SYK
|
25.4 B | $ 321.43 | -0.02 % | $ 123 B | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Tactile Systems Technology
TCMD
|
55 M | $ 23.57 | - | $ 539 M | ||
|
TELA Bio
TELA
|
75.1 M | $ 0.78 | - | $ 36.6 M | ||
|
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | ||
|
TransMedics Group
TMDX
|
595 M | $ 101.26 | - | $ 3.44 B | ||
|
Tandem Diabetes Care
TNDM
|
726 M | $ 18.63 | - | $ 1.27 B | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 5.16 | - | $ 1.09 B | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Vivos Therapeutics
VVOS
|
26.7 M | $ 0.85 | - | $ 8.73 M | ||
|
Beyond Air
XAIR
|
15.7 M | $ 0.51 | - | $ 34.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.14 | - | $ 355 M | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 10.55 | - | $ 378 M | ||
|
Xtant Medical Holdings
XTNT
|
43.2 M | $ 0.55 | -1.78 % | $ 76.7 M | ||
|
Zimmer Biomet Holdings
ZBH
|
8.89 B | $ 82.8 | - | $ 16.8 B | ||
|
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.04 | - | $ 17.6 M | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 36.79 | - | $ 1.14 B |